CRISPR Investments: Potential vs Reality
Despite plateauing venture funding in gene editing, the potential of CRISPR technology to revolutionize agriculture is still believed to be ...
- Latest
- Trending
Despite plateauing venture funding in gene editing, the potential of CRISPR technology to revolutionize agriculture is still believed to be ...
Pesticides harm ecosystems by killing various insects, not just targeted ones. The mayor of Suzano hopes for a 20% reduction ...
NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Ventyx Biosciences, Inc. (VTYX) is a high-risk investment with negative net income and high debt ratio, but analysts recommend buying ...
Adial Pharmaceuticals, Inc. - A biopharmaceutical company focusing on addiction therapeutics. Stock faced challenges this year, with price drops. Leadership ...
Exciting news from Adam Feuerstein! His informative and spicy newsletter will debut tomorrow. Brazilian government aiming to reduce healthcare costs ...
Published results show a 36-month survival rate of 20% with immunotherapy. ICI resistant group had a 72% 12-month OS rate. ...
South Korean conglomerate LG Corp. plans to invest $10 billion in artificial intelligence and battery production for electric vehicles.
EuropaBio's Director General emphasizes the need for Europe to take action in the field of biotechnology and not just be ...
The growing AI in drug discovery market is driven by the increasing amount of data in drug development. However, restraints ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.